Here’s whether Precigen, Inc. Common Stock (PGEN) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+10.28% over 10 days); RSI 60 — healthy momentum range; strong 1-year return of +229.7%; 3-month momentum positive (+38.0%); rising volume confirms the move (1.46x 30d avg). Currently 16.7% off its 52-week high. Score: +8/7.
PGEN is in a confirmed uptrend, trading above both its 50-day ($5.45) and 200-day ($4.42) moving averages. An RSI of 60.4 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +229.7% compares to +20.4% for SPY (beat the market by 209.4%).
$10,000 invested 1 year ago→ $32,973 today
vs. S&P 500 (SPY) — same period beat market by 209.4%